COVID-19 Vaccine Of Moderna Shows Good Efficacy In Clinical Trials
Moderna's COVID-19 vaccine mRNA-1273,- shows an efficacy of 94.1 percent in preventing symptomatic COVID-19. Mild adverse reactions of the vaccine were fatigue, muscle aches, joint pain and headaches.
No comments:
Post a Comment